211 related articles for article (PubMed ID: 30670153)
1. Proteolytic cleavages of MET: the divide-and-conquer strategy of a receptor tyrosine kinase.
Fernandes M; Duplaquet L; Tulasne D
BMB Rep; 2019 Apr; 52(4):239-249. PubMed ID: 30670153
[TBL] [Abstract][Full Text] [Related]
2. Necrosis- and apoptosis-related Met cleavages have divergent functional consequences.
Montagne R; Berbon M; Doublet L; Debreuck N; Baranzelli A; Drobecq H; Leroy C; Delhem N; Porte H; Copin MC; Dansin E; Furlan A; Tulasne D
Cell Death Dis; 2015 May; 6(5):e1769. PubMed ID: 25996296
[TBL] [Abstract][Full Text] [Related]
3. MET receptor variant R970C favors calpain-dependent generation of a fragment promoting epithelial cell scattering.
Montagne R; Baranzelli A; Muharram G; Catherine L; Lesaffre M; Vinchent A; Kherrouche Z; Werkmeister E; Cortot AB; Tulasne D
Oncotarget; 2017 Feb; 8(7):11268-11283. PubMed ID: 28061464
[TBL] [Abstract][Full Text] [Related]
4. Caspase cleavage of the MET receptor generates an HGF interfering fragment.
Deheuninck J; Foveau B; Goormachtigh G; Leroy C; Ji Z; Tulasne D; Fafeur V
Biochem Biophys Res Commun; 2008 Mar; 367(3):573-7. PubMed ID: 18187039
[TBL] [Abstract][Full Text] [Related]
5. Met degradation: more than one stone to shoot a receptor down.
Lefebvre J; Ancot F; Leroy C; Muharram G; Lemière A; Tulasne D
FASEB J; 2012 Apr; 26(4):1387-99. PubMed ID: 22223753
[TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic role of caspase-cleaved GAB1 adaptor protein in hepatocyte growth factor/scatter factor-MET receptor protein signaling.
Le Goff A; Ji Z; Leclercq B; Bourette RP; Mougel A; Guerardel C; de Launoit Y; Vicogne J; Goormachtigh G; Fafeur V
J Biol Chem; 2012 Oct; 287(42):35382-35396. PubMed ID: 22915589
[TBL] [Abstract][Full Text] [Related]
7. The MET receptor tyrosine kinase in invasion and metastasis.
Benvenuti S; Comoglio PM
J Cell Physiol; 2007 Nov; 213(2):316-25. PubMed ID: 17607709
[TBL] [Abstract][Full Text] [Related]
8. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.
Kemp LE; Mulloy B; Gherardi E
Biochem Soc Trans; 2006 Jun; 34(Pt 3):414-7. PubMed ID: 16709175
[TBL] [Abstract][Full Text] [Related]
9. The shadow of death on the MET tyrosine kinase receptor.
Tulasne D; Foveau B
Cell Death Differ; 2008 Mar; 15(3):427-34. PubMed ID: 17917681
[TBL] [Abstract][Full Text] [Related]
10. Shedding-generated Met receptor fragments can be routed to either the proteasomal or the lysosomal degradation pathway.
Ancot F; Leroy C; Muharram G; Lefebvre J; Vicogne J; Lemiere A; Kherrouche Z; Foveau B; Pourtier A; Melnyk O; Giordano S; Chotteau-Lelievre A; Tulasne D
Traffic; 2012 Sep; 13(9):1261-72. PubMed ID: 22672335
[TBL] [Abstract][Full Text] [Related]
11. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
Niemann HH
Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
[TBL] [Abstract][Full Text] [Related]
13. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
14. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.
Foveau B; Ancot F; Leroy C; Petrelli A; Reiss K; Vingtdeux V; Giordano S; Fafeur V; Tulasne D
Mol Biol Cell; 2009 May; 20(9):2495-507. PubMed ID: 19297528
[TBL] [Abstract][Full Text] [Related]
16. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
17. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
To CT; Tsao MS
Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
[TBL] [Abstract][Full Text] [Related]
18. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
19. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
